Philadelphia, PA, United States of America

Callum Hicks



 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Callum Hicks: Innovator in Therapeutic Compounds

Introduction

Callum Hicks is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of therapeutic compounds, particularly in addressing social disorders and substance use disorders. With a total of 3 patents, Hicks is dedicated to advancing medical treatments that can improve the quality of life for individuals affected by these conditions.

Latest Patents

Hicks' latest patents focus on therapeutic compounds and compositions designed for treating neurological and psychiatric disorders. These disorders are characterized by a fundamental disruption of social behavior and substance use issues. The patents disclose compounds of Formula (I), along with their salts or prodrugs, and outline methods for treating or preventing these disorders using the specified compounds.

Career Highlights

Throughout his career, Callum Hicks has been associated with Kinoxis Therapeutics Pty Ltd, where he has been instrumental in developing innovative therapeutic solutions. His work has garnered attention for its potential impact on mental health treatment and the management of substance use disorders.

Collaborations

Hicks collaborates with esteemed colleagues, including Iain Stewart McGregor and Michael Thomas Bowen. Their combined expertise contributes to the advancement of therapeutic research and development.

Conclusion

Callum Hicks stands out as an influential inventor in the realm of therapeutic compounds, with a focus on addressing critical social and substance use disorders. His innovative work continues to pave the way for new treatment methodologies that can significantly benefit those in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…